Skip Navigation


American Journal of Epidemiology Advance Access originally published online on November 10, 2007
American Journal of Epidemiology 2007 166(12):1480-1481; doi:10.1093/aje/kwm323
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
166/12/1480    most recent
kwm323v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rosenberg, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberg, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology © The Author 2007. Published by the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

LETTERS TO THE EDITOR

RE: "INVITED COMMENTARY: HORMONE THERAPY AND RISK OF CORONARY HEART DISEASE—WHY RENEW THE FOCUS ON THE EARLY YEARS OF MENOPAUSE?"

Lynn Rosenberg

School of Medicine - Slone Epidemiology Unit, Boston University, Brookline, MA 02146

(e-mail: lrosenberg@slone.bu.edu)

The first 10% of the full text of this article appears below.

Manson and Bassuk (1) discuss a theory, "the timing hypothesis," advanced to explain the discrepancy between the results of observational studies that have suggested a protective effect of supplemental female hormone use against coronary heart . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?